Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Detke

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Primary Care Companion to the Journal of Clinical Psychiatry|July 16, 2004
Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary IncontinenceLars Viktrup, Beth A. Pangallo, Michael J. Detke, et al.
Depression and Anxiety|July 22, 2005
Time course of depression-symptom improvement during treatment with duloxetineRobert M A Hirschfeld, Craig Mallinckrodt, Thomas C Lee, et al.
Journal of Anxiety Disorders|October 24, 2006
Is PTSD caused by traumatic stress?J Alexander Bodkin, Harrison G Pope, Michael J Detke, et al.
Depression and Anxiety|September 10, 2003
Duloxetine in treatment of anxiety symptoms associated with depressionDavid L Dunner, David J Goldstein, Craig Mallinckrodt, et al.
Pain|June 2, 2005
Duloxetine vs. placebo in patients with painful diabetic neuropathyDavid J Goldstein, Yili Lu, Michael J Detke, et al.
Journal of Psychiatric Research|May 9, 2006
Management of depression relapse: re-initiation of duloxetine treatment or dose increaseMaurizio Fava, Michael J Detke, Matteo Balestrieri, et al.
Psychopharmacology Bulletin|May 22, 2007
Simple options for improving signal detection in antidepressant clinical trialsCraig H Mallinckrodt, Adam L Meyers, Apurva Prakash, et al.
The Journal of Clinical Psychiatry|May 4, 2004
The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?Maurizio Fava, Craig H Mallinckrodt, Michael J Detke, et al.
Current Medical Research and Opinion|October 3, 2008
The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorderDavid A Fishbain, Michael J Detke, Joachim Wernicke, et al.
The Journal of Clinical Psychiatry|May 10, 2002
Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trialMichael J Detke, Yili Lu, David J Goldstein, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Primary Care Companion to the Journal of Clinical Psychiatry|July 16, 2004
Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary IncontinenceLars Viktrup, Beth A. Pangallo, Michael J. Detke, et al.
Depression and Anxiety|July 22, 2005
Time course of depression-symptom improvement during treatment with duloxetineRobert M A Hirschfeld, Craig Mallinckrodt, Thomas C Lee, et al.
Journal of Anxiety Disorders|October 24, 2006
Is PTSD caused by traumatic stress?J Alexander Bodkin, Harrison G Pope, Michael J Detke, et al.
Depression and Anxiety|September 10, 2003
Duloxetine in treatment of anxiety symptoms associated with depressionDavid L Dunner, David J Goldstein, Craig Mallinckrodt, et al.
Pain|June 2, 2005
Duloxetine vs. placebo in patients with painful diabetic neuropathyDavid J Goldstein, Yili Lu, Michael J Detke, et al.
Journal of Psychiatric Research|May 9, 2006
Management of depression relapse: re-initiation of duloxetine treatment or dose increaseMaurizio Fava, Michael J Detke, Matteo Balestrieri, et al.
Psychopharmacology Bulletin|May 22, 2007
Simple options for improving signal detection in antidepressant clinical trialsCraig H Mallinckrodt, Adam L Meyers, Apurva Prakash, et al.
The Journal of Clinical Psychiatry|May 4, 2004
The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?Maurizio Fava, Craig H Mallinckrodt, Michael J Detke, et al.
Current Medical Research and Opinion|October 3, 2008
The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorderDavid A Fishbain, Michael J Detke, Joachim Wernicke, et al.
The Journal of Clinical Psychiatry|May 10, 2002
Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trialMichael J Detke, Yili Lu, David J Goldstein, et al.
Pageof 6